Legal & General Group PLC Icosavax, Inc. Transaction History

Legal & General Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$5.95 - $15.79 $761 - $2,021	128 Added 5.74%	2,359 $37,000
Q3 2023 Nov 14, 2023	SELL	$7.22 - $10.05 $3,003 - $4,180	-416 Reduced 15.72%	2,231 $17,000
Q2 2023 Aug 14, 2023	BUY	$4.89 - $10.57 $3,393 - $7,335	694 Added 35.54%	2,647 $26,000
Q2 2022 Aug 22, 2022	SELL	$5.7 - $10.33 $15,087 - $27,343	-2,647 Reduced 57.54%	1,953 $11,000
Q1 2022 May 16, 2022	BUY	$4.41 - $22.5 $4,687 - $23,917	1,063 Added 30.05%	4,600 $32,000

Q4 2021 Feb 14, 2022	BUY	$21.07 - $34.98 $48,123 - $79,894	2,284 Added 182.28%	3,537 $81,000
Q3 2021 Nov 15, 2021	BUY	$24.85 - $40.25 $31,137 - $50,433	1,253 New	1,253 $37,000

1.37M

Ticker ICVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,885,200
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.